Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
INR 70.01
(-1.3%)
INR 70.01
(-1.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 482.09 Million | 470.43 Million | 380.86 Million | 316.66 Million | 399.81 Million | 379.78 Million |
| Cost of Revenue | 238.16 Million | 219.84 Million | 188.23 Million | 156.52 Million | 189.49 Million | 181.79 Million |
| Gross Profit | 243.93 Million | 250.59 Million | 192.62 Million | 160.13 Million | 210.31 Million | 197.99 Million |
| Operating Expenses | 35.11 Million | 204.53 Million | 158.28 Million | 144.85 Million | 194.76 Million | 193.35 Million |
| Selling, General and Administrative Expenses | 34.57 Million | 33.99 Million | 15.06 Million | 8.52 Million | 19.45 Million | 19.89 Million |
| Research and Development Expenses | 536 Thousand | 488 Thousand | 831 Thousand | 498 Thousand | - | - |
| Other Expenses | - | 11.45 Million | 4.35 Million | 3.51 Million | 4.57 Million | 5.12 Million |
| Cost and Expenses | 381.55 Million | 424.37 Million | 346.52 Million | 301.38 Million | 384.25 Million | 375.14 Million |
| Operating Income | 100.54 Million | 50.32 Million | 36.43 Million | 14.3 Million | 16.18 Million | 4.64 Million |
| Interest Expense | 2 Million | 976 Thousand | 283 Thousand | 563 Thousand | 539 Thousand | 359 Thousand |
| Income Tax Expense | 10.99 Million | 15.74 Million | 11.09 Million | 4.24 Million | 3.9 Million | -802 Thousand |
| Earnings before Tax | 40.13 Million | 56.52 Million | 40.93 Million | 19.92 Million | 14.55 Million | 6.27 Million |
| Net Income | 29.14 Million | 40.77 Million | 29.84 Million | 15.68 Million | 10.64 Million | 7.08 Million |
| Earnings Per Share Basic | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 |
| Earnings Per Share Diluted | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 |
| Weighted Average Shares Outstanding | 20.81 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.81 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.82 Million |
| Gross Margin | 0.51 | 0.53 | 0.51 | 0.51 | 0.53 | 0.52 |
| EBIT Margin | 0.16 | 0.19 | 0.17 | 0.14 | 0.12 | 0.11 |
| Profit Margin | 0.06 | 0.09 | 0.08 | 0.05 | 0.03 | 0.02 |
| EBITDA | 79.42 Million | 88.36 Million | 68.08 Million | 44.59 Million | 41.14 Million | 36.39 Million |
| Earnings Before Tax Margin | 0.21 | 0.11 | 0.10 | 0.05 | 0.04 | 0.01 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 128.9 Million | 482.09 Million | 108.83 Million | 120.29 Million | 127.29 Million | 125.67 Million |
| Cost of Revenue | 99.66 Million | 364.7 Million | 90 Million | 91.98 Million | 61.1 Million | 58.28 Million |
| Gross Profit | 29.24 Million | 117.39 Million | 18.83 Million | 28.31 Million | 66.19 Million | 67.38 Million |
| Operating Expenses | 23.16 Million | 89.37 Million | 22.47 Million | 22.34 Million | 56.99 Million | 50.88 Million |
| Selling, General and Administrative Expenses | 23.16 Million | - | 22.47 Million | 22.34 Million | 23.48 Million | 21.06 Million |
| Research and Development Expenses | - | - | 536 Thousand | - | - | - |
| Other Expenses | 3.06 Million | 13.02 Million | 3.99 Million | 3.47 Million | 2.69 Million | 2.86 Million |
| Cost and Expenses | 122.83 Million | 454.07 Million | 112.47 Million | 114.32 Million | 118.09 Million | 109.17 Million |
| Operating Income | 6.07 Million | 28.02 Million | -3.64 Million | 5.97 Million | 11.9 Million | 16.49 Million |
| Interest Expense | 567 Thousand | 974 Thousand | 317 Thousand | 362 Thousand | 133 Thousand | 163 Thousand |
| Income Tax Expense | 2.33 Million | 10.99 Million | -190 Thousand | 2.41 Million | 3.35 Million | 5.41 Million |
| Earnings before Tax | 8.56 Million | 40.13 Million | 54 Thousand | 8.98 Million | 11.85 Million | 19.25 Million |
| Net Income | 6.23 Million | 29.14 Million | 243 Thousand | 6.56 Million | 8.49 Million | 13.83 Million |
| Earnings Per Share Basic | 0.30 | - | 0.01 | 0.32 | 0.41 | 0.67 |
| Earnings Per Share Diluted | 0.30 | - | 0.01 | 0.32 | 0.41 | 0.67 |
| Weighted Average Shares Outstanding | 20.79 Million | 20.81 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.79 Million | 20.81 Million | 20.79 Million | 20.79 Million | 20.79 Million | 20.79 Million |
| Gross Margin | 0.23 | 0.24 | 0.17 | 0.24 | 0.52 | 0.54 |
| EBIT Margin | 0.13 | - | 0.07 | 0.13 | 0.16 | 0.21 |
| Profit Margin | 0.05 | 0.06 | 0.00 | 0.05 | 0.07 | 0.11 |
| EBITDA | 16.64 Million | - | 7.58 Million | 15.78 Million | 20.83 Million | 26.66 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | -0.03 | 0.05 | 0.09 | 0.13 |
HHFA
WN-PA
CTG
GBFH
MXHN
DIE